What QLQ-C15-PAL Symptoms Matter Most for Overall Quality of Life in Patients With Advanced Cancer?

Overview

Journal World J Oncol

Specialty Oncology

Date 2017 Nov 18

PMID 29147243

Citations 3

Authors

Amanda Caissie

Shaelyn Culleton

Janet Nguyen

Liying Zhang

Liang Zeng

Lori Holden

Kristopher Dennis

Esther Chan

Florencia Jon

May Tsao

Cyril Danjoux

Arjun Sahgal

Elizabeth Barnes

Kaitlin Koo

Edward Chow

Affiliations

Soon will be listed here.

Abstract

Background: Few studies have evaluated the QLQ-C15-PAL health-related quality of life (QOL) questionnaire, an abbreviated version of the QLQ-C30 questionnaire that was designed specifically for patients with advanced cancer. The present study assessed whether certain symptoms or functional domains from the QLQ-C15-PAL predicted overall QOL when rated prior to palliative radiation treatment (RT).

Patients And Methods: Patients attending an outpatient palliative radiotherapy clinic completed QLQ-C15-PAL questionnaires prior to palliative RT for bone, brain or lung disease. Pearson correlations were computed between the QLQ-C15-PAL functional/symptom scores and overall QOL scores. Multiple linear regressions were used to evaluate the relative importance of functional/symptom scales in association with overall QOL.

Results: Data from 369 patients were analyzed. The QLQ-C15-PAL domains of physical and emotional functioning, pain, and appetite loss were significant predictors of overall QOL in these patients with advanced cancer. Appetite loss was the only significant independent predictor of overall QOL in the subgroup of patients with advanced lung cancer (n = 29). Both appetite loss and emotional functioning were independently predictive of overall QOL in patients with bone metastases (n = 190). In patients with brain metastases (n = 150), independent predictors of overall QOL included physical and emotional functioning as well as fatigue.

Conclusion: The QLQ-C15-PAL domains of physical and emotional functioning, pain and appetite loss were significant predictors of overall QOL in this cohort of patients with advanced cancer. Different functional and symptom scales predicted overall QOL in patients with bone metastases, brain metastases or advanced lung cancer.

Citing Articles

Individual changes in neurocognitive functioning and health-related quality of life in patients with brain oligometastases treated with stereotactic radiotherapy.

van der Meer P, Habets E, Wiggenraad R, Verbeek-de Kanter A, Lycklama A Nijeholt G, Zwinkels H J Neurooncol. 2018; 139(2):359-368.

PMID: 29663172 PMC: 6096889. DOI: 10.1007/s11060-018-2868-7.

Evaluation of Quality of Life Outcomes Following Palliative Treatment of Bone Metastases with Magnetic Resonance-guided High Intensity Focused Ultrasound: An International Multicentre Study.

Harding D, Giles S, Brown M, Ter Haar G, van den Bosch M, Bartels L Clin Oncol (R Coll Radiol). 2018; 30(4):233-242.

PMID: 29317145 PMC: 5842401. DOI: 10.1016/j.clon.2017.12.023.

Cancer cachexia: impact, mechanisms and emerging treatments.

Vaughan V, Martin P, Lewandowski P J Cachexia Sarcopenia Muscle. 2012; 4(2):95-109.

PMID: 23097000 PMC: 3684701. DOI: 10.1007/s13539-012-0087-1.

References

Rustoen T, Moum T, Padilla G, Paul S, Miaskowski C . Predictors of quality of life in oncology outpatients with pain from bone metastasis. J Pain Symptom Manage. 2005; 30(3):234-42. DOI: 10.1016/j.jpainsymman.2005.04.002. View

Chow E, Hird A, Velikova G, Johnson C, DeWolf L, Bezjak A . The European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire for patients with bone metastases: the EORTC QLQ-BM22. Eur J Cancer. 2008; 45(7):1146-1152. DOI: 10.1016/j.ejca.2008.11.013. View

Echteld M, Deliens L, Onwuteaka-Philipsen B, Klein M, van der Wal G . EORTC QLQ-C15-PAL: the new standard in the assessment of health-related quality of life in advanced cancer?. Palliat Med. 2006; 20(1):1-2. DOI: 10.1191/0269216306pm1090ed. View

Elmqvist M, Jordhoy M, Bjordal K, Kaasa S, Jannert M . Health-related quality of life during the last three months of life in patients with advanced cancer. Support Care Cancer. 2008; 17(2):191-8. DOI: 10.1007/s00520-008-0477-2. View

Aaronson N, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez N . The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993; 85(5):365-76. DOI: 10.1093/jnci/85.5.365. View

Beijer S, Kempen G, Pijls-Johannesma M, de Graeff A, Dagnelie P . Determinants of overall quality of life in preterminal cancer patients. Int J Cancer. 2008; 123(1):232-5. DOI: 10.1002/ijc.23497. View

Arnold R, Ranchor A, Sanderman R, Kempen G, Ormel J, Suurmeijer T . The relative contribution of domains of quality of life to overall quality of life for different chronic diseases. Qual Life Res. 2004; 13(5):883-96. DOI: 10.1023/B:QURE.0000025599.74923.f2. View

Gerrard G, Prestwich R, Edwards A, Russon L, Richards F, Johnston C . Investigating the palliative efficacy of whole-brain radiotherapy for patients with multiple-brain metastases and poor prognostic features. Clin Oncol (R Coll Radiol). 2003; 15(7):422-8. DOI: 10.1016/s0936-6555(03)00148-1. View

Suarez-del-Real Y, Allende-Perez S, Alferez-Mancera A, Rodriguez R, Jimenez-Toxtle S, Mohar A . Validation of the Mexican-Spanish version of the EORTC QLQ-C15-PAL questionnaire for the evaluation of health-related quality of life in patients on palliative care. Psychooncology. 2010; 20(8):889-96. DOI: 10.1002/pon.1801. View

10.

Sloan J, Aaronson N, Cappelleri J, Fairclough D, Varricchio C . Assessing the clinical significance of single items relative to summated scores. Mayo Clin Proc. 2002; 77(5):479-87. View

11.

Groenvold M, Petersen M, Aaronson N, Arraras J, Blazeby J, Bottomley A . The development of the EORTC QLQ-C15-PAL: a shortened questionnaire for cancer patients in palliative care. Eur J Cancer. 2005; 42(1):55-64. DOI: 10.1016/j.ejca.2005.06.022. View

12.

Wilson I, Cleary P . Linking clinical variables with health-related quality of life. A conceptual model of patient outcomes. JAMA. 1995; 273(1):59-65. View

13.

Churm D, Andrew I, Holden K, Hildreth A, Hawkins C . A questionnaire study of the approach to the anorexia-cachexia syndrome in patients with cancer by staff in a district general hospital. Support Care Cancer. 2008; 17(5):503-7. DOI: 10.1007/s00520-008-0486-1. View

14.

Ostlund U, Wennman-Larsen A, Gustavsson P, Wengstrom Y . What symptom and functional dimensions can be predictors for global ratings of overall quality of life in lung cancer patients?. Support Care Cancer. 2007; 15(10):1199-205. DOI: 10.1007/s00520-007-0239-6. View

15.

Chow E, Bottomley A . Understanding the EORTC QLQ-BM22, the module for patients with bone metastases. Expert Rev Pharmacoecon Outcomes Res. 2009; 9(5):461-5. DOI: 10.1586/erp.09.50. View

16.

Roos D, Wirth A, Burmeister B, Spry N, Drummond K, Beresford J . Whole brain irradiation following surgery or radiosurgery for solitary brain metastases: mature results of a prematurely closed randomized Trans-Tasman Radiation Oncology Group trial (TROG 98.05). Radiother Oncol. 2006; 80(3):318-22. DOI: 10.1016/j.radonc.2006.08.004. View

17.

Movsas B . Quality of life in oncology trials: a clinical guide. Semin Radiat Oncol. 2003; 13(3):235-47. DOI: 10.1016/S1053-4296(03)00029-8. View

18.

Bowling A . Just one question: If one question works, why ask several?. J Epidemiol Community Health. 2005; 59(5):342-5. PMC: 1733095. DOI: 10.1136/jech.2004.021204. View

19.

Rosemann T, Hermann K, Miksch A, Engeser P, Szecsenyi J . The PAMINO-project: evaluating a primary care-based educational program to improve the quality of life of palliative patients. BMC Palliat Care. 2007; 6:5. PMC: 1892546. DOI: 10.1186/1472-684X-6-5. View

20.

. Study protocol for the World Health Organization project to develop a Quality of Life assessment instrument (WHOQOL). Qual Life Res. 1993; 2(2):153-9. View